Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Mol Sci ; 16(8): 17088-100, 2015 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-26225962

RESUMEN

S-Methylmethionine sulfonium (SMMS) was reported to have wound-healing effects; we therefore have investigated the photoprotective effect of SMMS in the present study. SMMS increased the viability of keratinocyte progenitor cells (KPCs) and human dermal fibroblasts (hDFs) following ultraviolet B (UVB) irradiation, and reduced the UVB-induced apoptosis in these cells. SMMS increased the phosphorylation of extracellular signal-regulated kinases (ERK), and the inhibitor of the mitogen-activated protein kinase pathway significantly decreased the SMMS-induced viability of KPCs and hDFs. In addition, SMMS attenuated the UVB-induced reactive oxygen species (ROS) generation in KPCs and hDFs. SMMS induced the collagen synthesis and reduced the matrix metalloproteinase-1 expression in UVB-irradiated hDFs. In animal studies, application of 5% and 10% SMMS before and after UVB-irradiation significantly decreased the UVB-induced erythema index and depletion of Langerhans cells. In summary, SMMS protects KPCs and hDFs from UVB irradiation, and reduces UVB-induced skin erythema and immune suppression. Therefore, SMMS can be used as a cosmetic raw material, and protect skin from UVB.


Asunto(s)
Eritema/tratamiento farmacológico , Piel/efectos de los fármacos , Protectores Solares/farmacología , Vitamina U/farmacología , Vitaminas/farmacología , Animales , Línea Celular , Colágeno/genética , Colágeno/metabolismo , Eritema/etiología , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibroblastos/efectos de la radiación , Humanos , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Queratinocitos/efectos de la radiación , Metaloproteinasa 1 de la Matriz/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo , Piel/efectos de la radiación , Protectores Solares/uso terapéutico , Rayos Ultravioleta/efectos adversos , Vitamina U/uso terapéutico , Vitaminas/uso terapéutico
2.
Lik Sprava ; (3-4): 87-94, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-26827446

RESUMEN

The article summarizes clinical features of the course when chronic pancreatitis goes in combination with diseases of gastroduodenal and hepatobiliary systems and features of functional and morphological changes. The article also represents justification of need to include the combined medicine Doktovit (combination of Dexpanthenol and S-methylmethionine) into complex treatment of the pathology, describes mechanism of its gastro protective and reparative action.


Asunto(s)
Antioxidantes/uso terapéutico , Enfermedades Duodenales/fisiopatología , Hepatopatías/fisiopatología , Pancreatitis Crónica/fisiopatología , Sustancias Protectoras/uso terapéutico , Gastropatías/fisiopatología , Enfermedades Duodenales/complicaciones , Enfermedades Duodenales/tratamiento farmacológico , Enfermedades Duodenales/metabolismo , Hemo/análogos & derivados , Hemo/uso terapéutico , Humanos , Hepatopatías/complicaciones , Hepatopatías/tratamiento farmacológico , Hepatopatías/metabolismo , Meglumina/análogos & derivados , Meglumina/uso terapéutico , Pancreatitis Crónica/complicaciones , Pancreatitis Crónica/tratamiento farmacológico , Pancreatitis Crónica/metabolismo , Ácido Pantoténico/uso terapéutico , Gastropatías/complicaciones , Gastropatías/tratamiento farmacológico , Gastropatías/metabolismo , Succinatos/uso terapéutico , Vitamina U/uso terapéutico
3.
Naunyn Schmiedebergs Arch Pharmacol ; 391(2): 177-184, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29218374

RESUMEN

The aim of this study is to investigate the therapeutic effects of vitamin U (Vit U) on lung tissue of pentyleneterazole (PTZ)-induced seizures in rats. Sprague Dawley male rats were randomly divided into four groups as follows: control (0.9% NaCl given, intraperitoneally); Vit U (50 mg/kg/day, for 7 days by gavage); PTZ; (60 mg/kg one dose, intraperitoneally); and PTZ + Vit U (in same dose and time). At the end of the experiment, lung tissues were taken and examined biochemically and cytologically. Lipid peroxidation (LPO), glutathione (GSH), sialic acid (SA), and nitric oxide (NO) levels, and superoxide dismutase (SOD) and catalase (CAT) activities were determined in lung homogenates. Imprinted lung samples were stained with May Grunwald-Giemsa stain and microscopically examined for the presence of collagen fibers, macrophage, leucocyte, and epithelial cells. PTZ administration significantly increased GSH level and CAT activity and significantly decreased SOD activity compared to the control group. Vit U administration significantly increased GSH level and CAT activity compared to the control group. GSH and NO levels significantly decreased in PTZ + Vit U group compared to the PTZ group. In cytologic analysis, increased collagen fibers, macrophages, leucocytes, and epithelial cells were observed in PTZ group compared to the control group, and Vit U administration decreased these cytological parameters compared to the PTZ group. The findings of this study support the possible protective role of using Vit U as an add-on therapy in order to prevent lung tissue injury which may occur during seizures in epilepsy.


Asunto(s)
Pulmón/metabolismo , Pentilenotetrazol/toxicidad , Convulsiones/tratamiento farmacológico , Convulsiones/metabolismo , Vitamina U/uso terapéutico , Animales , Peroxidación de Lípido/efectos de los fármacos , Peroxidación de Lípido/fisiología , Pulmón/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Ratas , Ratas Sprague-Dawley , Convulsiones/inducido químicamente , Resultado del Tratamiento , Vitamina U/farmacología
4.
Aust Vet J ; 85(9): 362-7, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17760939

RESUMEN

OBJECTIVE: To assess the value of s-methylmethionine sulphonium chloride (SMMSC) (200 mg/kg) on nutritional performance of pigs and as prevention or therapy for oesophagogastric ulcers. DESIGN: Sixty pigs from a high health status herd with continuing oesophagogastric ulcer problems were endoscopically assessed for the presence or absence of oesophagogastric ulcers. Forty-eight pigs were then selected and allocated according to an initial oesophagogastric epithelial (ulcer score) classification to replicated treatment groups in a 2 x 2 factorial design. Weight gain and feed intake were measured over 49 d, after which pigs were killed and stomachs were collected, re-examined and scored for oesophagogastric ulceration. RESULTS: There was no difference over the 49 d in weight gain, feed intake and backfat in pigs with and without SMMSC supplementation between pigs with or without fully developed oesophagogastric ulcers at the start of the study. In pigs with an initially low ulcer score, feeding SMMSC did not prevent further oesophagogastric ulcer development. No significant effect of SMMSC was apparent when final mean oesophagogastric ulcer scores were compared in pigs with existing high ulcer score. However, further analysis of the changes in individual pig oesophagogastric ulcer scores during the experiment showed that the observed reductions in scores of the high ulcer group was significantly different from all other groups. CONCLUSION: This study has indicated that supplementation of pig diets with SMMSC cannot be justified unless the slight ulcer score improvement observed could be translated to some commercial production advantage such as a reduction in pig mortalities due to oesophagogastric ulcers. This study has further confirmed the benefit of endoscopy as a tool to enable objective assessment of oesophageal gastric health.


Asunto(s)
Antiulcerosos/uso terapéutico , Enfermedades del Esófago/veterinaria , Úlcera Gástrica/veterinaria , Compuestos de Sulfonio/uso terapéutico , Enfermedades de los Porcinos/tratamiento farmacológico , Vitamina U/uso terapéutico , Alimentación Animal , Animales , Enfermedades del Esófago/tratamiento farmacológico , Enfermedades del Esófago/patología , Enfermedades del Esófago/prevención & control , Índice de Severidad de la Enfermedad , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/patología , Úlcera Gástrica/prevención & control , Porcinos , Enfermedades de los Porcinos/patología , Enfermedades de los Porcinos/prevención & control , Resultado del Tratamiento , Aumento de Peso
5.
Eksp Klin Farmakol ; 69(2): 37-9, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-16845938

RESUMEN

Gastrobiol--a new preparation comprising a mixture of lyophilized sea-buckthorn oil, vitamin U, and magnesium oxide, produces a pronounced antiulcerous action on the mucous membrane of the stomach and duodenum. The regenerative effect of gastrobiol is more pronounced than that of pure sea-buckthorn oil and methyluracil.


Asunto(s)
Antiulcerosos/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Hippophae/química , Óxido de Magnesio/uso terapéutico , Aceites de Plantas/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Vitamina U/uso terapéutico , Animales , Combinación de Medicamentos , Úlcera Duodenal/inducido químicamente , Ratas , Ratas Endogámicas , Úlcera Gástrica/inducido químicamente
6.
Hum Exp Toxicol ; 34(9): 904-10, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25504687

RESUMEN

Valproic acid (2-propyl-pentanoic acid, VPA) is the most widely prescribed antiepileptic drug due to its ability to treat a broad spectrum of seizure types. VPA exhibits various side effects such as organ toxicity, teratogenicity, and visual disturbances. S-Methylmethioninesulfonium is a derivative of the amino acid methionine and it is widely referred to as vitamin U (Vit U). This study was aimed to investigate the effects of Vit U on lens damage parameters of rats exposed to VPA. Female Sprague Dawley rats were divided into four groups. Group I comprised control animals. Group II included control rats supplemented with Vit U (50 mg/kg/day) for 15 days. Group III was given only VPA (500 mg/kg/day) for 15 days. Group IV was given VPA + Vit U (in same dose and time). Vit U was given to rats by gavage and VPA was given intraperitoneally. On the 16th day of experiment, all the animals which were fasted overnight were killed. Lens was taken from animals, homogenized in 0.9% saline to make up to 10% (w/v) homogenate. The homogenates were used for protein, glutathione, lipid peroxidation levels, and antioxidant enzymes activities. Lens lipid peroxidation levels and aldose reductase and sorbitol dehydrogenase activities were increased in VPA group. On the other hand, glutathione levels, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, and paraoxonase activities were decreased in VPA groups. Treatment with Vit U reversed these effects. This study showed that Vit U exerted antioxidant properties and may prevent lens damage caused by VPA.


Asunto(s)
Anticonvulsivantes/toxicidad , Depuradores de Radicales Libres/uso terapéutico , Enfermedades del Cristalino/inducido químicamente , Enfermedades del Cristalino/prevención & control , Ácido Valproico/toxicidad , Vitamina U/uso terapéutico , Vitaminas/uso terapéutico , Animales , Antioxidantes/metabolismo , Femenino , Cristalino/patología , Peroxidación de Lípido/efectos de los fármacos , Ratas , Ratas Sprague-Dawley
7.
J Pharm Sci ; 81(7): 698-700, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1403707

RESUMEN

Reserpine (intraperitoneal, 5 mg/kg every day for 5 days) produced chronic ulceration of the rat stomach 2 weeks postdose. Gavage with 1% DL-cysteine or DL-methionine-S-methylsulfonium chloride at 1 mL/day for 2 weeks and 5 days protected against ulceration in 30% of the rats, and this protection extended to 80% of cases with 2% solutions. Similar gavage with 5% solutions protected all rats against ulceration without significantly influencing the basal H+ output [13.1 +/- 0.3 and 14.2 +/- 0.2 mumol for DL-cysteine and DL-methionine-S-methylsulfonium chloride, respectively, versus 15.1 +/- 0.4 mumol (mean +/- standard error of the mean; n = 10)]; that is, cytoprotection was achieved.


Asunto(s)
Cisteína/uso terapéutico , Úlcera Gástrica/prevención & control , Vitamina U/uso terapéutico , Animales , Cisteína/administración & dosificación , Femenino , Masculino , Ratas , Ratas Endogámicas , Reserpina , Úlcera Gástrica/inducido químicamente , Vitamina U/administración & dosificación
8.
J Pharm Sci ; 81(1): 70-3, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1619573

RESUMEN

One milliliter of 1, 2, or 5% DL-cysteine (cysteine) or DL-methionine methylsulfonium chloride (MMSC) was instilled into the rat stomach 1, 24, and 48 h after giving ethanol (1 mL of 40% solution) by gavage. One hour following the administration of ethanol, gastric mucosal injury was seen in all the animals (22.6 +/- 1.1 mm2, mean +/- SEM; n = 10). Twenty-four hours after giving the ethanol, all the rats treated with cysteine or MMSC still had the mucosal injury. Treatment with 2% cysteine or MMSC significantly (p less than 0.01) reduced the extent of this injury (10.2 +/- 0.6 and 10.1 +/- 0.5 mm2, respectively, versus 20.7 +/- 1.2 mm2, mean +/- SEM; n = 10), an action that was similarly achieved by the 5% solutions (10.1 +/- 0.5 and 9.9 +/- 0.3 mm2, respectively, versus 20.7 +/- 1.2 mm2, mean +/- SEM; n = 10). Forty-eight hours following the administration of ethanol, 30% of the animals given 1% cysteine or MMSC still had gastric mucosal injury, which was significantly (p less than 0.001) less extensive than that seen with ethanol alone (3.8 +/- 0.3 and 4.1 +/- 0.3 mm2, respectively, versus 13.1 +/- 0.8 mm2, mean +/- SEM; n = 10). At this time period, however, none of the animals treated with 2 or 5% solutions of cysteine or MMSC still had any injury. Healing of the ethanol-induced injury was confirmed microscopically and was achieved by regeneration.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Cisteína/farmacología , Mucosa Gástrica/efectos de los fármacos , Gastritis/tratamiento farmacológico , Úlcera Gástrica/tratamiento farmacológico , Vitamina U/farmacología , Animales , Cisteína/administración & dosificación , Cisteína/uso terapéutico , Relación Dosis-Respuesta a Droga , Etanol/toxicidad , Femenino , Mucosa Gástrica/patología , Gastritis/patología , Masculino , Ratas , Ratas Endogámicas , Reserpina , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/patología , Vitamina U/administración & dosificación , Vitamina U/uso terapéutico
9.
Vet Rec ; 137(12): 290-3, 1995 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-8533223

RESUMEN

Four groups of about 86 pigs from a common source were fed a grower diet from 25 kg to 45 kg liveweight, and then from 45 to 107 kg liveweight they were offered one of four diets ad libitum: A) normal commercial feed, ground through a 3 mm screen (the control diet), B) the same diet ground through a 6 mm screen, C) the control diet to which lucerne meal was added before the diet was ground to increase its crude fibre content, and D) the control diet to which was added 400 ppm S-methylmethionine-sulphonium chloride (MMSC). All the diets were pelleted. Approximately 21 per cent of the animals fed the control diet had severe oesophagogastric erosions and/or ulcers after slaughter. The addition of 400 ppm MMSC decreased (P = 0.066) the proportion of severe oesophagogastric erosions and/or ulcers by about 50 per cent compared with the control diet. The diet with the higher crude fibre content (but finely ground) did not have a significant effect on the proportion of severe oesophagogastric erosions and/or ulcers. There was a tendency for the pigs fed the diet ground through a 6 mm screen instead of a 3 mm screen, to have fewer severe oesophagogastric erosions and/or ulcers. However, there were only small differences between the particle size distribution obtained from the wet sieve analysis of the two diets. As a result, the observed tendency for a decrease in the proportion of severe oesophagogastric erosions and/or ulcers in pigs fed the diet milled through the larger screen size was of questionable significance.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Alimentación Animal , Fibras de la Dieta , Enfermedades del Esófago/veterinaria , Úlcera Gástrica/veterinaria , Enfermedades de los Porcinos/tratamiento farmacológico , Porcinos/crecimiento & desarrollo , Vitamina U/uso terapéutico , Animales , Enfermedades del Esófago/tratamiento farmacológico , Úlcera Gástrica/tratamiento farmacológico , Úlcera/tratamiento farmacológico , Úlcera/veterinaria
10.
Artículo en Ruso | MEDLINE | ID: mdl-7315057

RESUMEN

Results of treating depressive states (manic-depressive psychosis, involutional and vascular depressions) with S-methylmethionine (vitamin "U") are presented. The vitamin was found to produce a marked antidepressant effect in depressive states of various nosology irrespectively of the duration of the depression phase or preceding treatment. The authors suggest that studies of the effect of the vitamin and its clinical use as an antidepressant should be continued.


Asunto(s)
Antidepresivos , Trastorno Depresivo/tratamiento farmacológico , Trastornos Neurocognitivos/tratamiento farmacológico , Vitamina U/uso terapéutico , Vitaminas/uso terapéutico , Adulto , Anciano , Antidepresivos/efectos adversos , Trastorno Bipolar/tratamiento farmacológico , Trastornos Cerebrovasculares/complicaciones , Femenino , Humanos , Persona de Mediana Edad , Síndrome , Vitamina U/efectos adversos
11.
Eksp Klin Farmakol ; 61(5): 21-3, 1998.
Artículo en Ruso | MEDLINE | ID: mdl-9854627

RESUMEN

In experimental study of antiulcerative activity of dibunol on various models of gastric ulcers in rats the drug caused a marked antiulcerative effect in all of them, reduced the incidence of ulcer formation, and shortened the time of ulcer healing. In a model of "acetic" ulcer dibunol oil solution led to quick normalization of lipid peroxidation in the gastric mucosa, which was evidence of high antioxidant activity in cases of ulcer lesions.


Asunto(s)
Antiulcerosos/uso terapéutico , Antioxidantes/uso terapéutico , Hidroxitolueno Butilado/uso terapéutico , Animales , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Ratas , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/etiología , Úlcera Gástrica/metabolismo , Factores de Tiempo , Vitamina E/uso terapéutico , Vitamina U/uso terapéutico
12.
Vopr Onkol ; 31(4): 46-53, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-4002669

RESUMEN

The study was concerned with the functional condition of the sympatho-adrenal system in 80 patients with cancer of the esophagus and proximal part of the stomach who had undergone surgery and received combined treatment, coupled with measures aimed at correcting the sympatho-adrenal system in some cases. Treatment with phenformin, decaris and S-methylmethionine was shown to produce a favorable effect on certain stages of catecholamine synthesis and metabolism as well as on immunologic indexes and hemodynamic stability.


Asunto(s)
Médula Suprarrenal/fisiopatología , Neoplasias Esofágicas/fisiopatología , Neoplasias Gástricas/fisiopatología , Sistema Nervioso Simpático/fisiopatología , Médula Suprarrenal/efectos de los fármacos , Adulto , Anciano , Catecolaminas/metabolismo , Terapia Combinada , Epinefrina , Neoplasias Esofágicas/inmunología , Neoplasias Esofágicas/cirugía , Neoplasias Esofágicas/terapia , Esófago/cirugía , Femenino , Gastrectomía , Humanos , Inmunoglobulina M/análisis , Levamisol/uso terapéutico , Masculino , Persona de Mediana Edad , Fenformina/uso terapéutico , Formación de Roseta , Neoplasias Gástricas/inmunología , Neoplasias Gástricas/cirugía , Neoplasias Gástricas/terapia , Sistema Nervioso Simpático/efectos de los fármacos , Vitamina U/uso terapéutico
13.
Food Chem Toxicol ; 50(10): 3562-6, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22889891

RESUMEN

In this study, we aimed to investigate the effects of vitamin U (Vit U) on valproic acid (VPA)-induced liver damage. Female Sprague Dawley rats were randomly divided into four groups. Group I was intact control animals. Group II was control rats given Vit U (50 mg/kg/day) for fifteen days. Group III was given only VPA (500 mg/kg/day) for fifteen days. Group IV was given VPA+Vit U (in same dose and time). Vit U was given to rats by gavage and VPA was given intraperitoneally. On the 16th day of experiment, all the animals were fasted overnight and then sacrificed under ether anesthesia. Liver tissue was taken from animals, homogenized in 0.9% saline to make up to 10% homogenate. Liver aspartate and alanine transaminases, alkaline phosphatase, lactate dehydrogenase, myeloperoxidase, sorbitol dehydrogenase, glutamate dehydrogenase and xanthine oxidase activities and lipid peroxidation levels were increased and paraoxonase activity and glutathione levels were decreased in VPA group. Treatment with Vit U reversed these effects. These results demonstrated that administration of Vit U is a potentially beneficial agent to reduce the liver damage in VPA induced hepatotoxicity, probably by decreasing oxidative stress.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Ácido Valproico/toxicidad , Vitamina U/uso terapéutico , Animales , Femenino , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley
14.
Metallomics ; 3(7): 683-5, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21701765

RESUMEN

The insulinomimetic activity of a Zn(ii) complex is reported. The effects of the Zn(ii) complex with ascorbic acid (Vitamin C; VC), methylmethionine sulfonium chloride (Vitamin U; VU) and l-carnitine were assessed in diet-induced metabolic syndrome model rats. Zn(VU)(2)Cl(2) and Zn(VC)Cl(2) were suggested to be useful supplementary materials for preventing metabolic syndrome by reducing visceral adipose tissues or accelerating blood fluidity.


Asunto(s)
Ácido Ascórbico/uso terapéutico , Carnitina/uso terapéutico , Síndrome Metabólico/tratamiento farmacológico , Vitamina U/uso terapéutico , Zinc/uso terapéutico , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Tejido Adiposo/patología , Animales , Ácido Ascórbico/farmacología , Peso Corporal/efectos de los fármacos , Carnitina/farmacología , Separación Celular , Dieta , Modelos Animales de Enfermedad , Ácidos Grasos/metabolismo , Conducta Alimentaria/efectos de los fármacos , Glucosa/farmacología , Concentración 50 Inhibidora , Insulina/análogos & derivados , Síndrome Metabólico/prevención & control , Ratas , Vitamina U/farmacología , Zinc/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA